In 2020, the net profit of Yirui biology declined by 29.1%, and the salary of chairman Zhu Hai was 322000 yuan



On May 6, erui bio (300942) recently released its 2020 annual report. During the reporting period, the company achieved an operating revenue of 258455671.51 yuan, up 8.06% year on year; The net profit attributable to shareholders of listed companies was 65445058.17 yuan, down 29.10% year on year.


易瑞生物2020年净利下滑29.1% 董事长朱海薪酬32.2万

During the reporting period, the net cash flow from operating activities was 63793860.76 yuan, and the net assets attributable to shareholders of listed companies were 549053562.88 yuan by the end of 2020.

During the reporting period, the company achieved a total operating revenue of 258.4557 million yuan, an increase of 8.06% over the same period of last year; The operating profit was 75.105 million yuan, down 28.63% over the same period of last year; The total profit was 73.9433 million yuan, down 30.27% over the same period of last year; The net profit attributable to shareholders of listed companies was 65.4451 million yuan, down 29.10% over the same period of last year; The net profit attributable to shareholders of listed companies after deducting non recurring profits and losses was 56.8778 million yuan, a decrease of 24.89% over the same period of last year. During the reporting period, the overall operation of the company was stable and the financial situation was good. The factors influencing the decline of profit index included: the administrative expenses intermediary agency expenses increased by 10.8254 million yuan over the same period of last year, mainly due to the lawyer fees and consulting fees related to the company’s handling of Spanish public opinion matters; The loss of asset impairment increased by 13.3974 million yuan over the same period of last year, mainly due to the provision for related inventory depreciation; Financial expenses increased by 11.8595 million yuan over the same period of last year, mainly due to the increase of exchange loss caused by exchange rate changes.

According to the announcement, the total remuneration of directors, supervisors and senior managers during the reporting period was 3.7477 million yuan. Zhu Hai, the chairman of the board, received a total pre tax remuneration of 322000 yuan from the company, Lu Hehua, the director and general manager, received a total pre tax remuneration of 230100 yuan from the company, and Wang Guangsheng, the chief financial officer, received a total pre tax remuneration of 356200 yuan from the company.

According to digbei.com, iResearch is mainly engaged in the R & D, production, sales and related services of food safety accurate and rapid detection products, and expands to the field of in vitro diagnostic rapid detection (POCT).

 


发表评论

邮箱地址不会被公开。 必填项已用*标注